Jump to content
  • Content Count

    2,505
  • Joined

  • Last visited

Patient Safety Learning

Administrators

Community Reputation

79 Good

3 Followers

About Patient Safety Learning

  • Rank
    Senior

Recent Profile Visitors

The recent visitors block is disabled and is not being shown to other users.

  1. Content Article
    Key findings 281 nurses who died by suicide were identified over the six-year study period; of these 204 (73%) were female – these were the main focus of the study. Female nurses were older than other women who died by suicide; nearly half were aged 45-54 years. The most common method of suicide for female nurses was self-poisoning (42%). • More than half (60%) of female nurses who died were not in contact with mental health services. 102 nurses who died were identified as patients; of these, 81 (79%) were female and their clinical histories were examined further. Their age distribution was similar to that of nurses in the general population who die by suicide, 40% being aged 45-54 years. Female nurses who were patients were similar to female patients in other occupations. The main primary diagnoses were affective disorders (59%), followed by personality disorders (19%). Overall 41% had a history of alcohol misuse and 20% reported a history of drug misuse. Nearly two-thirds of female nurses had a history of self-harm (64%). Self-poisoning accounted for 48% of the deaths by female nurses. The main drugs taken were psychotropics (33%), opiates (31%), and paracetamol (19%). Although prevalence of experiencing adverse life events within three months of death was similar across the groups, female nurses were reported to have more workplace problems (18%). There were few differences in the care received by the female nurses and by women in other occupations, though it was less common for nurses to have had a previous short psychiatric admission of seven days or fewer, and they were more often prescribed SSRIs/SNRIs.
  2. Content Article
    Over 200,000 babies were born when lockdown was at its most restrictive, between 23 March and 4 July. The survey of 5,474 respondents suggests that the impact of COVID-19 on these babies could be severe and may be longlasting. The report found: 6 in 10 (61%) parents shared significant concerns about their mental health. A quarter (24%) of pregnant respondents who cited mental health as a main concern said they would like help with this, rising to almost a third (32%) of those with a baby. Only around 3 in 10 (32%) were confident that they could find help for their mental health if they needed it. Almost 9 in 10 (87%) parents were more anxious as a result of COVID-19 and the lockdown. There was a notable variation among respondents who reported feeling ‘a lot’ more anxious: White 42%, Black/ Black British 46%, Asian/Asian British 50%, parents 25 years old or under 54%, and parents with a household income of less than £16k 55%.
  3. Event
    until
    The COVID-19 pandemic has put a spotlight on the rights and needs of older persons. While everyone has been affected, evidence shows that older people are among those most at risk of complications from the disease, with fatality rates for those over 80 years of age five times the global average. They are also at greater risk of poverty, discrimination and isolation. Older persons have been hit particularly hard by the virus itself but it has been the failure to protect their rights in the response that has led to unnecessary deaths, unmet health and care needs, increased isolation, discrimination and stigma. This webinar will: Recognise the impact of COVID-19 on the wellbeing and dignity of older persons across the Commonwealth. Raise awareness of ageism, stigma and discrimination against older people in the COVID-19 response and the need to foster intergenerational connections across the Commonwealth. Reflect on how The Commonwealth needs to adapt to ensure the rights of its citizens of all ages are respected. Register
  4. News Article
    Tens of thousands of people infected with coronavirus were incorrectly given the all clear by England’s Lighthouse Laboratories, a High Court trial will be told next week. Court documents seen by The Independent show the labs are accused of unfairly selecting software that was shown in a test to produce significant numbers of errors and false negatives, samples that should have been positive or classed as needing to be re-taken. The two companies behind the Lighthouse Labs in England – Medicines Discovery Catapult Ltd and UK Biocentre Ltd – are accused of treating British company, Diagnostics.ai unfairly and giving preferential treatment to Belgian company UgenTec, despite the British firm’s software performing better in the test. The case, first revealed by The Independent in June, also includes a judicial review of the procurement decision against health secretary Matt Hancock – one of the first court hearings over the procurement processes followed by the government since the start of the pandemic. The Independent understands lawyers for Diagnostics.ai will accuse the laboratories of choosing a software solution that went on to produce tens of thousands of incorrect results which will have led to infected people going about their normal lives while at risk of spreading the virus. In June, UgenTec chief executive Steven Verhoeven told The Independent the suggestion its software had made errors was “incorrect”. The Department of Health refused to comment on the legal action but said in June that the UgenTec software had been used for several months and was subject to quality assurance processes, though it did not give any further details. Mr Justice Fraser will hear opening arguments in the case on Monday at the High Court. Read full story Source: The Independent, 25 September 2020
  5. Community Post
    https://questions-statements.parliament.uk/written-questions/detail/2020-09-09/87501
×